Expect crypto bulls to flock back to this space now that the Fed is cutting rates
A weekly look at the most important news and moves in crypto, and what’s on the horizon in digital assets.
Amgen’s stock falls 4% as analysts say drug updates lag competitors
The biotech offered an update on two drugs in development, but analysts said they’re not as effective as existing treatments.
Why now may be a good time to take ‘opportunistic’ profits in gold and silver
Gold prices are at their highest on record and silver recently touched a more than 11-year high. “Upside exhaustion” could make both due for a...
Sitting out August’s stock-market selloff paid off for retail investors
Most retail investors didn’t trade during the Aug. 5 selloff, and those who did largely bought the dip.
My husband’s pension was $8,000 a month. As his survivor, I only get $1,800. Can I fight this?
“We were together for eight years.”
Southwest Airlines’ investor day: 3 things to know ahead of ‘pivotal’ event
Thursday’s investor day comes as Southwest struggles to return to profitability and faces heated investor activism.
Another reason Qualcomm shouldn’t buy Intel? Its bonds could reach junk status.
GimmeCredit started coverage of Qualcomm’s bonds Wednesday with a bearish rating.
Ford, GM and Rivian may get caught by a ‘China butterfly effect,’ this investment bank says
Some U.S. auto makers are more vulnerable to increased competition from China and face market-share loss, analysts at Morgan Stanley say.
Buy the stocks of these companies helping fuel the ‘AI gold rush,’ analyst says
With demand for the use of artificial intelligence expected to continue to surge, Oppenheimer analyst Edward Yang recommended investors buy the stocks of a couple...